CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 126,450	$ 40,540
Restricted cash	12,413	13,593
Patient accounts receivable	313,373	296,785
Prepaid expenses	14,639	11,628
Other current assets	30,060	26,415
Total current assets	496,935	388,961
Property and equipment, net of accumulated depreciation of $92,422 and $101,364	41,845	16,026
Operating lease right of use assets	88,939	102,856
Goodwill	1,244,679	1,287,399
Intangible assets, net of accumulated amortization of $14,008 and $14,604	102,675	101,167
Other assets	85,097	79,836
Total assets	2,060,170	1,976,245
Current liabilities:
Accounts payable	28,237	43,735
Payroll and employee benefits	136,835	125,387
Accrued expenses	140,049	137,390
Termination fee paid by UnitedHealth Group	106,000	0
Current portion of long-term obligations	36,314	15,496
Current portion of operating lease liabilities	26,286	33,521
Total current liabilities	473,721	355,529
Long-term obligations, less current portion	361,862	419,420
Operating lease liabilities, less current portion	62,751	69,504
Deferred income tax liabilities	40,635	20,411
Other long-term obligations	1,418	4,808
Total liabilities	940,387	869,672
Commitments and Contingencies
Equity:
Preferred stock, $0.001 par value, 5,000,000 shares authorized; none issued or outstanding	0	0
Common stock, $0.001 par value, 60,000,000 shares authorized; 38,131,478 and 37,891,186 shares issued; and 32,667,631 and 32,511,465 shares outstanding	38	38
Additional paid-in capital	787,177	755,063
Treasury stock at cost, 5,463,847 and 5,379,721 shares of common stock	(468,626)	(461,200)
Retained earnings	747,925	757,672
Total Amedisys, Inc. stockholders’ equity	1,066,514	1,051,573
Noncontrolling interests	53,269	55,000
Total equity	1,119,783	1,106,573
Total liabilities and equity	$ 2,060,170	$ 1,976,245